Latest Investments News

Credit Corp Group maintains its FY25 NPAT guidance amid operational gains in US debt buying and cautious optimism in Australian/New Zealand lending markets.

Regis Healthcare reveals strong first-half FY25 financial results with rising occupancy and earnings, while gearing up for significant regulatory reforms under the new Aged Care Act effective July 2025.

Super Retail Group reports a 3.1% like-for-like sales growth in H2 FY25, driven by key brands and strategic investments in its omni-retail network and supply chain.

Super Retail Group reports steady sales growth driven by BCF and rebel brands, while facing increased costs from a new distribution centre and HR system upgrades.

360 Capital Group has extended the closing date for its Off-Market Equal Access Buy-Back by one week to 21 May 2025, offering eligible securityholders additional time to participate. This adjustment also shifts key dates for payment and cancellation of securities.

Tivan Limited has responded to ASX inquiries about a social media post by its executive chair concerning fluorite exploration, affirming compliance with disclosure rules and pending assay results.

Tivan Limited has locked in a $5 million share placement and signed a non-binding term sheet for a $51.3 million equity investment to fund the Speewah Fluorite Project, marking a significant step in its development plans.

Tivan Limited and Sumitomo Corporation have formalised a joint venture to develop the Speewah Fluorite Project in Western Australia, marking a major step toward establishing Australia’s inaugural fluorite mining and processing operation.

Global Data Centre Group updates its distribution guidance following the AirTrunk divestment, factoring in operational costs and risk reserves that temper immediate payouts.

ARC Funds Limited has secured $1.4 million through equity and debt to complete a strategic acquisition of a majority stake in The Term Deposit Shop, expanding its footprint in Australia's term deposit market.

National Australia Bank has reported robust half-year results with cash earnings of $3.58 billion and announced a fully franked interim dividend of 85 cents per share, underscoring its strong market position and strategic clarity.

Mayne Pharma has announced the expiration of the US antitrust waiting period, a critical step forward in Cosette Pharmaceuticals' proposed acquisition. The transaction now moves closer to completion, pending other regulatory and shareholder approvals.